These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30515999)

  • 1. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
    Cen M; Yao Y; Cui L; Yang G; Lu G; Fang L; Bao Z; Zhou J
    Cancer Med; 2018 Dec; 7(12):6205-6218. PubMed ID: 30515999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
    Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
    Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
    Pan J; Zhang Q; Liu Q; Komas SM; Kalyanaraman B; Lubet RA; Wang Y; You M
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1149-59. PubMed ID: 25245764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
    Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells.
    Zhu J; Xu S; Gao W; Feng J; Zhao G
    Life Sci; 2019 Mar; 221():204-211. PubMed ID: 30708101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
    Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Ko YB
    Int J Mol Med; 2019 May; 43(5):1969-1978. PubMed ID: 30864681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.
    Yuan H; Li ZM; Shao J; Ji WX; Xia W; Lu S
    J Exp Clin Cancer Res; 2017 May; 36(1):72. PubMed ID: 28558758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
    Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
    Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
    Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML
    Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.
    Terai H; Soejima K; Yasuda H; Nakayama S; Hamamoto J; Arai D; Ishioka K; Ohgino K; Ikemura S; Sato T; Yoda S; Satomi R; Naoki K; Betsuyaku T
    Mol Cancer Res; 2013 Jul; 11(7):759-67. PubMed ID: 23536707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
    Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.
    Tan Q; Wang Z; Wang Q; Wang Y; Huang Z; Su N; Jin M; Kuang L; Qi H; Ni Z; Li C; Zhu Y; Jiang W; Chen H; Deng C; Du X; Xie Y; Chen L
    Int J Biol Sci; 2018; 14(10):1389-1398. PubMed ID: 30123084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
    Jiang QQ; Fan LY; Yang GL; Guo WH; Hou WL; Chen LJ; Wei YQ
    BMC Cancer; 2008 Aug; 8():242. PubMed ID: 18706101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
    Deng S; Zhang C; Yang L; Ma L
    Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.